Skip to main content

Beneficial ownership — 13D / 13G

87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
RA CAPITAL MANAGEMENT, L.P. BCYC Bicycle Therapeutics PLC 13G 5% 2y
Trigran Investments, Inc. TTGT TechTarget, Inc. 13G/A 10.3% 2y
New SCS Spur Holdco, LLC PUMP ProPetro Holding Corp. 13G/A 0% 2y
Vimal Mehta BTAIQ BioXcel Therapeutics, Inc. 13D/A 23.5% 2y
ARYA Sciences Holdings IMTX Immatics N.V. 13G/A 0% 2y
Jacobs Private Equity II, LLC QXO QXO, Inc. 13D/A 89.86% 2y
Nistec Golan Ltd. ELTK Eltek Ltd 13D/A 52.58% 2y
Bpifrance Participations S.A. CSTM Constellium SE 13D/A 8.6% 2y
RA CAPITAL MANAGEMENT, L.P. CLYM Climb Bio, Inc. 13D/A 44.3% 2y
GOLDMAN SACHS GROUP INC MIR Mirion Technologies, Inc. 13D/A 9.6% 2y
SSR Mining Inc. EMX EMX Royalty Corporation 13G/A 4.58% 2y
Insight Holdings Group, LLC DIBS 1stdibs.com, Inc. 13G/A 0% 2y
Wellington Trust Company, NA SILC Silicom Ltd. 13G/A 1.25% 2y
WELLINGTON MANAGEMENT GROUP LLP ACHC Acadia Healthcare Company, Inc. 13G/A 11.04% 2y
WELLINGTON MANAGEMENT GROUP LLP GPGI GPGI, Inc. 13G 12.91% 2y
WELLINGTON MANAGEMENT GROUP LLP SILC Silicom Ltd. 13G/A 1.35% 2y
WELLINGTON MANAGEMENT GROUP LLP G Genpact LTD 13G/A 0.39% 2y
WELLINGTON MANAGEMENT GROUP LLP FLEX Flex Ltd. 13G/A 10.14% 2y
VICTORY CAPITAL MANAGEMENT INC SSP E.W. SCRIPPS Co 13G/A 2.84% 2y
WELLINGTON MANAGEMENT GROUP LLP LXFR Luxfer Holdings PLC 13G/A 0% 2y
WELLINGTON MANAGEMENT GROUP LLP SAGE Sage Therapeutics, Inc 13G/A 0.07% 2y
BRANDES INVESTMENT PARTNERS, LP PKE Park Aerospace Corp 13G/A 10.43% 2y
BRANDES INVESTMENT PARTNERS, LP INVX Innovex International, Inc. 13G/A 10.03% 2y
WELLINGTON MANAGEMENT GROUP LLP FOUR Shift4 Payments, Inc. 13G/A 1.55% 2y
JENNISON ASSOCIATES LLC CABA Cabaletta Bio, Inc. 13G 11.1% 2y
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) NPAB New Providence Acquisition Corp. II Class A Common Stock 13G/A 7.21% 2y
PERCEPTIVE ADVISORS LLC IMTX Immatics N.V. 13D 7.9% 2y
Tether Holdings Limited BTDR Bitdeer Technologies Group 13D 25.1% 2y
Goodwood Inc. CSCIF COSCIENS Biopharma Inc. 13G 7.2% 2y
MMCAP International Inc. SPC IAUX i-80 Gold Corp. 13G 6.48% 2y
James N. Topper PHAT Phathom Pharmaceuticals, Inc. 13D/A 17.4% 2y
SIT INVESTMENT ASSOCIATES INC NQP NUVEEN PENNSYLVANIA QUALITY MUNICIPAL INCOME FUND 13D 6.19% 2y
GAMCO INVESTORS, INC. ET AL INVX Innovex International, Inc. 13D/A 6.41% 2y
SIT INVESTMENT ASSOCIATES INC NXJ NUVEEN NEW JERSEY QUALITY MUNICIPAL INCOME FUND 13D 5.83% 2y
Riot Platforms, Inc. KEEL Keel Infrastructure Corp. 13D/A 12% 2y
Silver Lake Group, L.L.C. DELL Dell Technologies Inc. 13D/A 18.9% 2y
Jacob D. Cohen MGRX Mangoceuticals, Inc. 13D/A 34.7% 2y
STATE FARM MUTUAL AUTOMOBILE INSURANCE CO HGTY Hagerty, Inc. 13D/A 63.9% 2y
Jay Lichter, Ph.D. (“Lichter”) JANX Janux Therapeutics, Inc. 13D/A 14.1% 2y
Brookstone Capital Management AAPR Innovator ETFs Trust 13G 10.04% 2y
Brookstone Capital Management BAPR Sageworth Trust Co 13G/A 5.19% 2y
GQG Partners LLC APP AppLovin Corp 13G/A 4.75% 2y
PZENA INVESTMENT MANAGEMENT LLC JELD JELD-WEN Holding, Inc. 13G 10% 2y
Gold Sino Assets Limited GGR Gogoro Inc. 13D/A 33.2% 2y
GREAT POINT PARTNERS LLC CNTX Context Therapeutics Inc. 13G 9.89% 2y
Brookstone Capital Management BAPR Sageworth Trust Co 13G/A 23.42% 2y
Brookstone Capital Management ACIO Aptus Collared Investment Opportunity ETF 13G/A 23.77% 2y
Brookstone Capital Management AAPR Innovator ETFs Trust 13G 11.88% 2y
Jefferies Financial Group Inc. OSI Osiris Acquisition Corp. 13D/A 0% 2y
MILLENNIUM MANAGEMENT LLC SLDB Solid Biosciences Inc. 13G 5.2% 2y